Influence of the Consciousness Energy Healing Treatment on the Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate

Sodium selenate is an important nutraceutical/pharmaceutical compound used for the prevention and treatment of cancer, diabetes, inflammatory diseases, etc. The objective of the current study was to investigate the impact of The Trivedi Effect® - Energy of Consciousness Healing Treatment (Biofield Energy Healing treatment) on physical, structural, thermal, and behavioral properties of sodium selenate using PXRD, PSD, FT-IR, UV-vis, TGA, and DSC analysis. Sodium selenate was divided into two parts – one part was control, while another part was treated with The Trivedi Effect® remotely by seven renowned Biofield Energy Healers and defined as The Trivedi Effect® Treated sample. The PXRD analysis showed a significant alteration of the crystallite size of the treated sample in the range of -34.41% to 33.27% compared to the control sample. However, the average crystallite size of the treated sample was significantly decreased by 7.85% compared with the control sample. The particle size of the treated sample at d10, d50, and d90 values were significantly reduced by 4.72%, 8.40%, and 32.33%, respectively compared with the control sample. Consequently, the surface area of the treated sample was significantly increased by 6.25% compared to the control sample. The control and treated FT-IR spectra indicated the presence of sharp and strong absorption bands at 886 cm-1 and 887 cm-1, respectively due to the Se=O stretching. The UV-vis spectroscopic analysis displayed that the wavelength for the maximum absorbance of the control and treated samples were at 204.6 and 204.9 nm, respectively. TGA analysis revealed that the total weight loss of the treated sample was reduced significantly by 5.64% compared with the control sample. The DSC analysis showed that the treated sample (94.63°C) had very close vaporization temperature than the control sample (94.97°C). But, the latent heat of vaporization was increased significantly in the treated sample by 7.06% compared to the control sample. Thus, The Trivedi Effect® - Energy of Consciousness Healing Treatment might lead to generate a new polymorphic form of sodium selenate, which would be more soluble, bioavailable, and thermally stable compared with the untreated sample. The Trivedi Effect® treated sodium selenate would be very useful to design better nutraceutical/pharmaceutical formulations that might offer better therapeutic response against inflammatory diseases, immunological disorders, stress, aging, infectious diseases, cancer, diabetes, heart diseases, Alzheimer’s disease, etc.

The current analysis revealed that The Trivedi Effect® - Energy of Consciousness Healing Treatment (Biofield Energy Healing Treatment) displayed the significant impact on the physicochemical and thermal properties of sodium selenate. The PXRD analysis showed the remarkable alteration of the crystallite size of the treated sample from -34.41% to 33.27% compared with the control sample. Overall, the average crystallite size of the treated sodium selenate was significantly decreased by 7.85% compared with the control sample. This result indicated that the crystal morphology of the treated sodium selenate was changed from the control sample and The Trivedi Effect® - Biofield Energy Healing might lead to a new polymorphic form of sodium selenate. The particle size of the Biofield Energy Treated sample at d10, d50, and d90 values were significantly decreased by 4.72%, 8.40%, and 32.33%, respectively compared with the control sample. Similarly, the surface area of the treated sample was significantly increased by 6.25% compared with the control sample. TGA analysis revealed that the total weight loss of the Biofield Energy Treated sample was reduced by 4.93% compared with the control sample. The DSC analysis revealed that the treated sample (95.10°C) had higher vaporization temperature than the control sample (94.80°C). The latent heat of vaporization was increased significantly in the Biofield Energy Treated sample by 7.06% compared to the control sample. Briefly, the Biofield Energy Treated sodium selenate might be a new polymorphic form (i.e. enantiotropic) of sodium selenate having reduced crystallite and particle size and increased surface area. Thus, The Trivedi Effect® treated sodium selenate could be more soluble, bioavailable, and thermally stable than the control sample. Hence, The Trivedi Effect® treated sodium selenate would be very useful to design better nutraceutical and/or pharmaceutical formulations that might offer better therapeutic response against various diseases such as diabetes mellitus, allergies, and septic shock; stress-related disorders like sleep disorder, insomnia, anxiety, depression, Attention Deficit Disorder (ADD), Attention Deficit Hyperactive Disorder (ADHD), mental restlessness (mind chattering), brain frog, low libido, impotency, lack of motivation, mood swings, fear of the future, confusion, migraines, headaches, forgetfulness, overwhelm, loneliness, worthlessness, indecisiveness, frustration, irritability, chronic fatigue, obsessive/compulsive behavior and panic attacks; inflammatory diseases and immunological disorders like Lupus, Systemic Lupus Erythematosus, Hashimoto Thyroiditis, Type 1 Diabetes, Asthma, Chronic peptic ulcers, Tuberculosis, Hepatitis, Chronic active hepatitis, Celiac Disease (gluten-sensitive enteropathy), Addison Disease, Crohn's disease, Graves’ Disease, Pernicious and Aplastic Anemia, Sjogren Syndrome, Irritable Bowel Syndrome (IBS), Multiple Sclerosis, Rheumatoid arthritis, Chronic periodontitis, Ulcerative colitis, Chronic sinusitis, Myasthenia Gravis, Atherosclerosis, Vasculitis, Dermatitis, Diverticulitis, Rheumatoid Arthritis, Reactive Arthritis, Alopecia Areata, Psoriasis, Scleroderma, Fibromyalgia, Chronic Fatigue Syndrome and Vitiligo; aging-related diseases like cardiovascular disease, arthritis, cancer, Alzheimer's disease, dementia, cataracts, osteoporosis, diabetes, hypertension, glaucoma, hearing loss, Parkinson's Disease, Huntington's Disease, Prion Disease, Motor Neurone Disease, Spinocerebellar Ataxia, Spinal muscular atrophy, Amyotrophic lateral sclerosis, Friedreich's Ataxia, Lewy Body Disease, chronic infections and much more.